Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
GEHC 
GE HealthCare Technologies Inc. (GEHC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: GEHC (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Below Average Performance
These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.
Number of Analysts
21 Analysts rated it
Well-followed company, solid analyst reports, reliable data for confident investing.
1 Year Target Price $91.2
1 Year Target Price $91.2
| 12 | Strong Buy |
| 4 | Buy |
| 5 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 1.78% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 01/09/2026 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 40.25B USD | Price to earnings Ratio 18.25 | 1Y Target Price 91.2 |
Price to earnings Ratio 18.25 | 1Y Target Price 91.2 | ||
Volume (30-day avg) 21 | Beta 1.23 | 52 Weeks Range 57.54 - 94.63 | Updated Date 01/9/2026 |
52 Weeks Range 57.54 - 94.63 | Updated Date 01/9/2026 | ||
Dividends yield (FY) 0.16% | Basic EPS (TTM) 4.83 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 10.95% | Operating Margin (TTM) 14.21% |
Management Effectiveness
Return on Assets (TTM) 5.46% | Return on Equity (TTM) 24.45% |
Valuation
Trailing PE 18.25 | Forward PE 18.59 | Enterprise Value 46897783550 | Price to Sales(TTM) 1.99 |
Enterprise Value 46897783550 | Price to Sales(TTM) 1.99 | ||
Enterprise Value to Revenue 2.32 | Enterprise Value to EBITDA 12.34 | Shares Outstanding 455521592 | Shares Floating 454077589 |
Shares Outstanding 455521592 | Shares Floating 454077589 | ||
Percent Insiders 0.27 | Percent Institutions 89.26 |
Upturn AI SWOT
GE HealthCare Technologies Inc.
Company Overview
History and Background
GE HealthCare Technologies Inc. was spun off from General Electric (GE) in January 2023, becoming an independent publicly traded company. Prior to the spin-off, it operated as a segment of GE, with a history of innovation in medical imaging, diagnostics, and patient monitoring dating back decades. Key milestones include the development of early MRI and CT scanners, and the continuous expansion of its portfolio through organic growth and strategic acquisitions within the healthcare technology space.
Core Business Areas
- Description: This segment offers a comprehensive portfolio of imaging technologies, including MRI, CT, X-ray, and ultrasound systems, as well as contrast media and related software solutions. These products are used for diagnosis and treatment planning across various medical specialties.
- Segment Name: Imaging
- Description: This segment provides advanced imaging and navigation technologies for minimally invasive procedures, such as cardiac catheterization, neurovascular interventions, and oncology treatments. It includes angiography systems, biopsy devices, and advanced software for procedural guidance.
- Segment Name: Interventional Solutions
- Description: This segment encompasses patient care solutions, including anesthesia delivery, respiratory care, and patient monitoring devices. It also includes digital solutions and software designed to improve workflow efficiency and patient outcomes.
- Segment Name: Perspectives
- Description: This segment focuses on ultrasound imaging systems for a wide range of clinical applications, from general imaging to specialized areas like cardiology and women's health. The portfolio includes both diagnostic and therapeutic ultrasound devices.
- Segment Name: Ultrasound
Leadership and Structure
GE HealthCare Technologies Inc. is led by a management team with extensive experience in the healthcare industry. The CEO is Peter J. Arduini. The company operates with a divisional structure aligned with its core business segments, enabling focused innovation and market responsiveness. The board of directors oversees the company's strategic direction and corporate governance.
Top Products and Market Share
Key Offerings
- Competitors: Siemens Healthineers,Philips,Canon Medical Systems
- Description: A high-performance computed tomography (CT) scanner designed for advanced imaging across various clinical applications, offering speed, image quality, and dose reduction. Competitors include Siemens Healthineers (SOMATOM series), Philips (Incisive CT), and Canon Medical Systems (Aquilion series). Market share data for specific product lines is proprietary, but GE Healthcare is a leading player in the CT market.
- Market Share:
- Product Name: Revolution CT Scanner
- Revenue:
- Competitors: Philips Healthcare,Mindray Medical International,Nihon Kohden Corporation
- Description: A portfolio of patient monitoring solutions that provide comprehensive data on vital signs for critical care, perioperative, and general care settings. Competitors include Philips Healthcare (IntelliVue), Mindray Medical International (BeneVision), and Nihon Kohden Corporation. GE Healthcare holds a significant share in the patient monitoring market.
- Market Share:
- Product Name: CARESCAPE Patient Monitoring Systems
- Revenue:
- Competitors: Philips Healthcare,Siemens Healthineers,Canon Medical Systems
- Description: A range of ultrasound systems for diagnostic imaging in various medical fields, including radiology, cardiology, and obstetrics/gynecology. Key competitors include Philips Healthcare (EPIQ series), Siemens Healthineers (ACUSON series), and Canon Medical Systems (Aplio series). GE Healthcare is a strong contender in the ultrasound market.
- Market Share:
- Product Name: LOGIQ Ultrasound Systems
- Revenue:
Market Dynamics
Industry Overview
The medical technology industry is characterized by continuous innovation, increasing demand for advanced diagnostics and treatments, and a growing focus on integrated digital solutions. Factors such as aging populations, rising chronic disease prevalence, and increased healthcare spending globally drive market growth. The industry is highly regulated and competitive, with a strong emphasis on research and development.
Positioning
GE HealthCare Technologies Inc. is a leading global medical technology, pharmaceutical diagnostics, and digital solutions innovator. Its competitive advantages stem from its broad product portfolio, strong brand recognition, extensive service network, and a history of technological innovation. The company is well-positioned to benefit from trends such as AI-driven diagnostics, personalized medicine, and the increasing adoption of digital health solutions.
Total Addressable Market (TAM)
The global healthcare market, encompassing medical devices, diagnostics, and digital health, is substantial and projected to grow significantly, estimated to be in the trillions of dollars annually. GE HealthCare Technologies Inc. operates across several key segments within this TAM, including medical imaging, patient monitoring, and interventional solutions, positioning it to capture a significant portion of these markets.
Upturn SWOT Analysis
Strengths
- Strong brand reputation and established market presence.
- Diversified product portfolio across multiple healthcare segments.
- Extensive global sales and service network.
- History of innovation and technological advancements.
- Significant installed base of equipment.
Weaknesses
- Potential for integration challenges post-spin-off from GE.
- Dependence on innovation and R&D to maintain competitiveness.
- Exposure to regulatory changes and reimbursement policies.
- Competition from nimble, specialized players.
Opportunities
- Growth in emerging markets.
- Expansion of digital health and AI-powered solutions.
- Increasing demand for minimally invasive procedures.
- Opportunities for strategic partnerships and acquisitions.
- Focus on precision health and personalized medicine.
Threats
- Intense competition from global medical technology companies.
- Rapid technological obsolescence.
- Economic downturns affecting healthcare spending.
- Cybersecurity threats to digital health platforms.
- Supply chain disruptions and raw material cost fluctuations.
Competitors and Market Share
Key Competitors
- Siemens Healthineers (SHL)
- Philips (PHIA)
- Canon Medical Systems (7751.T)
Competitive Landscape
GE HealthCare Technologies Inc. competes in a highly dynamic and competitive global market. Its strengths lie in its comprehensive portfolio, established brand, and extensive service network. However, competitors like Siemens Healthineers and Philips are also strong innovators with significant market share and global reach. GE HealthCare's ability to leverage its digital and AI capabilities will be crucial to maintaining and expanding its competitive edge.
Major Acquisitions
BK Medical
- Year: 2022
- Acquisition Price (USD millions): 1450
- Strategic Rationale: Acquisition of BK Medical, a leader in portable ultrasound solutions, aimed to expand GE HealthCare's offerings in the rapidly growing point-of-care ultrasound market, enhancing its ability to deliver advanced imaging at the patient's side.
Growth Trajectory and Initiatives
Historical Growth: Prior to its spin-off, the GE HealthCare segment demonstrated consistent revenue growth driven by product innovation and market expansion, particularly in imaging and diagnostics. The company has a history of strategic acquisitions that have contributed to its growth.
Future Projections: Analyst projections for GE HealthCare Technologies Inc. generally indicate continued revenue growth in the mid-single digits annually. Growth is expected to be driven by demand for advanced medical technologies, expansion in emerging markets, and the increasing adoption of its digital and AI-powered solutions. Investments in R&D and potential strategic collaborations are key to its future growth.
Recent Initiatives: Key recent initiatives include the continued integration of AI and digital solutions into its product offerings, focusing on enhancing diagnostic accuracy and workflow efficiency. The company is also prioritizing sustainability in its operations and product development, aligning with global environmental, social, and governance (ESG) trends.
Summary
GE HealthCare Technologies Inc. is a robust medical technology company with a diversified product portfolio and a strong global presence. Its history of innovation, coupled with strategic initiatives in digital health and AI, positions it well for future growth. While facing intense competition and market dynamics, the company's established market share and expanding offerings provide a solid foundation. Continued focus on R&D and operational efficiency will be key to navigating potential challenges and capitalizing on opportunities in the evolving healthcare landscape.
Similar Stocks
Sources and Disclaimers
Data Sources:
- GE HealthCare Technologies Inc. Investor Relations
- SEC Filings (10-K, 10-Q)
- Reputable financial news outlets (e.g., Bloomberg, Reuters)
- Industry analysis reports
Disclaimers:
This information is for informational purposes only and does not constitute financial advice or a recommendation to buy or sell any securities. Financial data and market share estimates are subject to change and may vary depending on the source and methodology used. Investors should conduct their own due diligence before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About GE HealthCare Technologies Inc.
Exchange NASDAQ | Headquaters Chicago, IL, United States | ||
IPO Launch date 2023-01-04 | President, CEO & Director Mr. Peter J. Arduini | ||
Sector Healthcare | Industry Health Information Services | Full time employees 53000 | Website https://www.gehealthcare.com |
Full time employees 53000 | Website https://www.gehealthcare.com | ||
GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The AVS segment provides ultrasound, image guided therapies, and interventional solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as women's health, cardiovascular, and comprehensive care ultrasound as well as surgical visualization and guidance products. The PCS segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring, diagnostic cardiology, consumables and services, digital solutions, maternal infant care, and anesthesia products. The PDx segment supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, and positron emission tomography to the radiology and nuclear medicine industries. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.